medigraphic.com
SPANISH

Acta Médica Grupo Angeles

Órgano Oficial del Hospital Angeles Health System
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
    • Names and affiliations of the Editorial Board
  • Policies
  • About us
    • Data sharing policy
    • Stated aims and scope
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 2

<< Back Next >>

Acta Med 2014; 12 (2)

Cerebral perfusion by magnetic resonance imaging as a predictor of the degree of malignancy in glioblastoma multiforme and histopathological correlation

Valenzuela DJA, Valencia HO, Carrillo MR, Gómez PMG, Sánchez CJA, Valenzuela TJ, Robles RF
Full text How to cite this article

Language: Spanish
References: 11
Page: 85-89
PDF size: 703.97 Kb.


Key words:

Glioblastoma multiforme, perfusion, angiogenesis, magnetic resonance.

ABSTRACT

The amount of tumor angiogenesis is a histological marker of high-grade neoplasia; it is currently possible to evaluate the amount of tumor vascularity with quantitative functional technique such as perfusion, including the mean relative cerebral blood volume by magnetic resonance; the amount of tumor vascularity is related with the histological findings in high-grade gliomas like glioblastoma multiforme; however, the pathological analysis are still the parameters in predicting the neoplastic behavior.


REFERENCES

  1. Hong XY, Wang J, Li Z. AGR2 expression is regulated by HIF-1 and contributes to growth and angiogenesis of glioblastoma. Cell Biochem Biophys. 2013; 67 (3): 1487-1495.

  2. Lignelli A, Khandji AG. Review of imaging techniques in the diagnosis and management of brain metastases. Neurosurg Clin N Am. 2011; 22: 15-25.

  3. Anton K, Baehring JM, Mayer T. Glioblastoma multiforme overview of current treatment and future perspectives. Hematol Oncol Clin N Am. 2012; 26: 825-853.

  4. Wen PY, Kesari S. Malignant gliomas in adults. NEJM N Engl J Med. 2008; 359 (5): 492-507.

  5. Jain R, Poisson L, Narang J. Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. Radiology. 2013; 267: 212-220.

  6. Sanz-Requena R, Revert-Ventura A, Martí-Bonmatí L. Quantitative MR perfusion parameters related to survival time in high-grade gliomas. European Society of Radiology. 2013; 23(12): 3456-3465.

  7. Essig M, Shiroishi MS, Nguyen TB et al. Perfusion MRI: the five most frequently asked technical question. AJR Am J Roentgenol. 2013; 200 (1): 24-34.

  8. Guzmán-de-Villoria JA, Fernández-García P, Mateos-Pérez JM. Estudio de la perfusión cerebral mediante técnicas de susceptibilidad magnética: técnica y aplicaciones. Radiología. 2012; 54(3): 208-220.

  9. Chen XZ, Yin XM, Ai L et al. Differentiation between brain glioblastoma multiforme and solitary metastasis: qualitative and quantitative analysis based on routine MR imaging. AJNR Am J Neuroradiol. 2012; 33 (10): 1907-1912.

  10. Blanchet L, Kroosfhof PWT, Postoma GJ et al. Discrimination between metastasis and glioblastoma multiforme based on morphometric analysis of MR images. AJNR Am J Neuroradiol. 2011; 32: 67-73.

  11. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am Neuroradiol. 2006; 27: 475-487.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med. 2014;12